All non-squamous NSCLC tested negative for EGFR mutation (assay: ABI Prism SNaPshot®, Life Technologies®, Carlsbad, CA, USA) as well as ALK and ROS1 translocation (immunohistochemistry using D5F3 and D4D6 clones, respectively). This evidence concerns the gene EGFR and non-small cell lung carcinoma.